🇺🇸 FDA
Pipeline program

BOTOX

M22-080

Phase 3 small_molecule completed

Quick answer

BOTOX for Masseter Muscle Prominence is a Phase 3 program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).

Program details

Company
AbbVie
Indication
Masseter Muscle Prominence
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials